We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Targets 13th Drug Maker In Zoloft Patent Battle

Law360 (April 12, 2007, 12:00 AM EDT) -- Israeli generic drug maker Teva Pharmaceutical Industries Ltd. has sued yet another pharmaceutical company in its ongoing patent battle over the exclusive rights to sell a generic version of Pfizer Inc.’s blockbuster drug Zoloft.

Canada’s Cobalt Pharmaceuticals has become the 13th target of Teva’s campaign against a group of drug makers it claims are launching their own versions of the anti-depressant in violation of its patent rights.

Teva filed the suit Tuesday in the U.S. District Court for the District of New Jersey, alleging that Ontario-based...
To view the full article, register now.